Intended Use: Semaglutide is designed for Research Purposes only.

Storage: Store the vial in a cool, dry place away from direct sunlight. Once reconstituted, keep refrigerated at 2-8°C.

Solubility: Reconstitute with bacteriostatic water for best results.

Shelf Life: The lyophilized form has a shelf life of 24 months when properly stored. Once reconstituted, refrigerate and use within 4-6 weeks.

Handling: Ensure sterile techniques are used to maintain the product’s integrity during research.

Mice Weight Loss Study
Semaglutide was tested in diet-induced obese mice once daily. Researchers noted consistent weight reduction and improved glucose tolerance, linked to decreased food intake.

Rat Metabolic Improvement
Chronic semaglutide administration in obese rats yielded reduced food consumption, improved insulin sensitivity, and lower fasting glucose. Scientists observed diminished hepatic lipid accumulation, implying semaglutide’s therapeutic promise in mitigating metabolic irregularities through sustained appetite control and enhanced glucose regulation.

Primate Findings
Long-term semaglutide treatment in primates resulted in steady weight loss and stable glucose levels. Weekly doses were well tolerated, with minimal side effects.

Enhances insulin secretion, reduces glucagon levels, and moderates gastric emptying. By helping to regulate post-meal blood sugar spikes and suppress appetite, it assists in lowering energy intake. This multi-faceted action promotes better glycemic control and fosters sustained weight management, making semaglutide a potent therapeutic candidate.